| Year |
Citation |
Score |
| 2023 |
Fang LZ, Linehan V, Licursi M, Alberto CO, Power JL, Parsons MP, Hirasawa M. Prostaglandin E activates melanin-concentrating hormone neurons to drive diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America. 120: e2302809120. PMID 37467285 DOI: 10.1073/pnas.2302809120 |
0.726 |
|
| 2023 |
Duncan JKS, Xu D, Licursi M, Joyce MA, Saffran HA, Liu K, Gohda J, Tyrrell DL, Kawaguchi Y, Hirasawa K. Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection. Frontiers in Immunology. 14: 930086. PMID 37197656 DOI: 10.3389/fimmu.2023.930086 |
0.774 |
|
| 2020 |
Chelakkot VS, Liu K, Yoshioka E, Saha S, Xu D, Licursi M, Dorward A, Hirasawa K. MEK reduces cancer-specific PpIX accumulation through the RSK-ABCB1 and HIF-1α-FECH axes. Scientific Reports. 10: 22124. PMID 33335181 DOI: 10.1038/s41598-020-79144-x |
0.758 |
|
| 2018 |
Fogarty LC, Flemmer RT, Geizer BA, Licursi M, Karunanithy A, Opferman JT, Hirasawa K, Vanderluit JL. Mcl-1 and Bcl-xL are essential for survival of the developing nervous system. Cell Death and Differentiation. PMID 30361616 DOI: 10.1038/S41418-018-0225-1 |
0.655 |
|
| 2018 |
Yoshioka E, Chelakkot VS, Licursi M, Rutihinda SG, Som J, Derwish L, King JJ, Pongnopparat T, Mearow K, Larijani M, Dorward AM, Hirasawa K. Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway. Theranostics. 8: 2134-2146. PMID 29721068 DOI: 10.7150/Thno.22641 |
0.738 |
|
| 2016 |
Licursi M, Alberto CO, Dias A, Hirasawa K, Hirasawa M. High-fat diet-induced downregulation of anorexic leukemia inhibitory factor in the brain stem. Obesity (Silver Spring, Md.). PMID 27663886 DOI: 10.1002/Oby.21647 |
0.732 |
|
| 2015 |
Licursi M, Carmona-Martinez RA, Razavi S, Hirasawa K. Promotion of Viral IRES-Mediated Translation Initiation under Mild Hypothermia. Plos One. 10: e0126174. PMID 25951166 DOI: 10.1371/Journal.Pone.0126174 |
0.65 |
|
| 2015 |
AbuSara N, Razavi S, Derwish L, Komatsu Y, Licursi M, Hirasawa K. Restoration of IRF1-dependent anticancer effects by MEK inhibition in human cancer cells. Cancer Letters. 357: 575-81. PMID 25497010 DOI: 10.1016/J.Canlet.2014.12.017 |
0.766 |
|
| 2015 |
Komatsu Y, Christian SL, Ho N, Pongnopparat T, Licursi M, Hirasawa K. Oncogenic Ras inhibits IRF1 to promote viral oncolysis. Oncogene. 34: 3985-93. PMID 25347735 DOI: 10.1038/Onc.2014.331 |
0.836 |
|
| 2015 |
Komatsu Y, Christian SL, Ho N, Pongnopparat T, Licursi M, Hirasawa K. 628. Oncogenic Ras Inhibits IRF1 To Promote Viral Oncolysis Molecular Therapy. 23: S249. DOI: 10.1016/S1525-0016(16)34237-X |
0.836 |
|
| 2014 |
Hebert M, Licursi M, Jensen B, Baker A, Milway S, Malsbury C, Grant VL, Adamec R, Hirasawa M, Blundell J. Single rapamycin administration induces prolonged downward shift in defended body weight in rats. Plos One. 9: e93691. PMID 24787262 DOI: 10.1371/Journal.Pone.0093691 |
0.457 |
|
| 2012 |
Christian SL, Zu D, Licursi M, Komatsu Y, Pongnopparat T, Codner DA, Hirasawa K. Suppression of IFN-induced transcription underlies IFN defects generated by activated Ras/MEK in human cancer cells. Plos One. 7: e44267. PMID 22970192 DOI: 10.1371/Journal.Pone.0044267 |
0.82 |
|
| 2012 |
Licursi M, Komatsu Y, Pongnopparat T, Hirasawa K. Promotion of viral internal ribosomal entry site-mediated translation under amino acid starvation. The Journal of General Virology. 93: 951-62. PMID 22302880 DOI: 10.1099/Vir.0.040386-0 |
0.773 |
|
| 2011 |
Licursi M, Christian SL, Pongnopparat T, Hirasawa K. In vitro and in vivo comparison of viral and cellular internal ribosome entry sites for bicistronic vector expression. Gene Therapy. 18: 631-6. PMID 21368899 DOI: 10.1038/Gt.2011.11 |
0.762 |
|
| 2009 |
Christian SL, Collier TW, Zu D, Licursi M, Hough CM, Hirasawa K. Activated Ras/MEK inhibits the antiviral response of alpha interferon by reducing STAT2 levels. Journal of Virology. 83: 6717-26. PMID 19386709 DOI: 10.1128/Jvi.02213-08 |
0.811 |
|
| Show low-probability matches. |